Justin Zelin
Stock Analyst at BTIG
(3.33)
# 2,403
Out of 4,476 analysts
331
Total ratings
36%
Success rate
3.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintained: Buy | $9 | $9.44 | -4.66% | 6 | Feb 2, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | $100 | $15.54 | +543.50% | 8 | Jan 22, 2026 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $2.14 | +320.56% | 5 | Jan 6, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $56 | $21.82 | +156.65% | 26 | Jan 2, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 | $34.67 | +29.80% | 2 | Jan 2, 2026 | |
| KURA Kura Oncology | Maintained: Hold | n/a | $11.10 | - | 20 | Dec 9, 2025 | |
| TCRX TScan Therapeutics | Reiterated: Hold | n/a | $1.06 | - | 10 | Dec 9, 2025 | |
| JSPR Jasper Therapeutics | Maintained: Buy | $7 | $0.4283 | +1,534.37% | 14 | Dec 2, 2025 | |
| AAPG Ascentage Pharma Group International | Maintained: Buy | $50 | $18.19 | +174.88% | 2 | Dec 2, 2025 | |
| BCAB BioAtla | Maintained: Buy | $500 | $4.19 | +11,833.17% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.50 | +344.44% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $37.65 | +64.67% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $37.44 | +233.87% | 36 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.81 | +343.21% | 2 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $49.82 | -9.67% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $29.91 | +204.25% | 38 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $32.49 | n/a | 13 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0061 | n/a | 5 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $9.00 | n/a | 21 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.03 | n/a | 10 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $8.18 | n/a | 15 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $0.703 | n/a | 22 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1469 | n/a | 8 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9504 | n/a | 14 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.387 | n/a | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.36 | n/a | 2 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.0011 | n/a | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $3 | $6.40 | n/a | 4 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $375.07 | n/a | 2 | Nov 11, 2020 |
ImmunityBio
Feb 2, 2026
Maintained: Buy
Price Target: $9
Current: $9.44
Upside: -4.66%
Janux Therapeutics
Jan 22, 2026
Maintained: Buy
Price Target: $100
Current: $15.54
Upside: +543.50%
NovaBridge Biosciences
Jan 6, 2026
Reiterated: Buy
Price Target: $9
Current: $2.14
Upside: +320.56%
Syndax Pharmaceuticals
Jan 2, 2026
Maintained: Buy
Price Target: $56
Current: $21.82
Upside: +156.65%
ArriVent BioPharma
Jan 2, 2026
Maintained: Buy
Price Target: $45
Current: $34.67
Upside: +29.80%
Kura Oncology
Dec 9, 2025
Maintained: Hold
Price Target: n/a
Current: $11.10
Upside: -
TScan Therapeutics
Dec 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.06
Upside: -
Jasper Therapeutics
Dec 2, 2025
Maintained: Buy
Price Target: $7
Current: $0.4283
Upside: +1,534.37%
Ascentage Pharma Group International
Dec 2, 2025
Maintained: Buy
Price Target: $50
Current: $18.19
Upside: +174.88%
BioAtla
Nov 14, 2025
Maintained: Buy
Price Target: $500
Current: $4.19
Upside: +11,833.17%
Nov 4, 2025
Reiterated: Buy
Price Target: $20
Current: $4.50
Upside: +344.44%
Nov 4, 2025
Reiterated: Buy
Price Target: $62
Current: $37.65
Upside: +64.67%
Oct 30, 2025
Reiterated: Buy
Price Target: $125
Current: $37.44
Upside: +233.87%
Sep 17, 2025
Reiterated: Buy
Price Target: $8
Current: $1.81
Upside: +343.21%
Aug 14, 2025
Reiterated: Buy
Price Target: $45
Current: $49.82
Upside: -9.67%
Aug 11, 2025
Reiterated: Buy
Price Target: $91
Current: $29.91
Upside: +204.25%
Mar 11, 2025
Reiterated: Buy
Price Target: $91
Current: $32.49
Upside: n/a
Jan 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0061
Upside: n/a
Sep 10, 2024
Maintained: Buy
Price Target: $6
Current: $9.00
Upside: n/a
Sep 3, 2024
Reiterated: Buy
Price Target: $5
Current: $2.03
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $30
Current: $8.18
Upside: n/a
Mar 12, 2024
Maintained: Buy
Price Target: $8
Current: $0.703
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.1469
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.9504
Upside: n/a
Dec 4, 2020
Initiated Coverage: Buy
Price Target: $4
Current: $0.387
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $4
Current: $1.36
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $28
Current: $0.0011
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $2 → $3
Current: $6.40
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $100
Current: $375.07
Upside: n/a